Literature DB >> 16904667

Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles.

A Rocha-Sousa1, J Saraiva, T Henriques-Coelho, F Falcão-Reis, J Correia-Pinto, A F Leite-Moreira.   

Abstract

Ghrelin is a recently described acylated peptide, which works as a somatosecretagogue and has described effects on the smooth, skeletal and cardiac muscle. We examined the production and effects of ghrelin on relaxation of the iris muscles. Contractile effects of 1-5 human ghrelin (frGhr, 10(-9)-6 x 10(-5)M) and 1-5 human des-octanoyl-ghrelin (d-frGhr; 10(-9)-6 x 10(-5)M) were tested on iris rabbit sphincter (n=11 frGhr; n=7 d-frGhr), dilator (n=6 frGhr; n=6 d-frGhr) and rat sphincter (n=6 frGhr; n=8 d-frGhr) precontracted muscles. On rabbit sphincter the effect of frGhr was also tested in presence of: i) L-NA (10(-5)M; n=7); ii) indomethacin (10(-5)M; n=7); iii) DLys(3)GHRP6 (10(-4)M; n=6); and iv) apamin+carybdotoxin (10(-6)M; n=6). Furthermore, on rabbit dilator the effect of frGhr was tested in presence of DLys(3)GHRP6 (10(-4)M; n=7). Finally, ghrelin mRNA production was assessed by "in situ" hybridization in Wistar rat eyes (n=8). In all muscles, frGhr promoted a concentration-dependent relaxation, maximal at 6 x 10(-5)M, 1.5-3 min after its addition, decreasing tension by 34.1+/-12.1%, 25.8+/-4.8% and 52.1+/-10.3% in the rabbit sphincter, dilator and rat sphincter, respectively. In the rabbit sphincter the relaxing effects of frGhr were: (i) enhanced in presence of DLys(3)GHRP6 (118.1+/-21.1%); (ii) blunted by indomethacin; and (iii) not altered by apamin+carybdotoxin (36.4+/-14.4%) or L-NA (52.4+/-11.4%). Relaxing effects of d-frGhr in rabbit (43.3+/-5.2%) and rat (77.1+/-15.3%) sphincter muscles were similar to those of frGhr. In rabbit dilator muscle, d-frGhr did not significantly alter active tension and the relaxing effect of frGhr was blunted by GHSR-1a blockage. Ghrelin mRNA was identified in iris posterior epithelium. In conclusion, ghrelin is a novel, locally produced, relaxing agent of iris dilator and sphincter muscles, an effect that is mediated by GHSR-1a in the former, but not in the latter. Furthermore, in the sphincter it seems to be mediated by prostaglandins, but not by NO or K(Ca) channels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904667     DOI: 10.1016/j.exer.2006.06.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  Aqueous humour levels of ghrelin in exfoliation syndrome and exfoliation glaucoma patients.

Authors:  Ayşe Vural Ozeç; Ayhan Dursun; Mustafa Ilker Toker; Yüksel Demirci; Aysen Topalkara; Haydar Erdoğan; Mustafa Kemal Arıcı; Taner Ersalcan
Journal:  Jpn J Ophthalmol       Date:  2014-05-08       Impact factor: 2.447

2.  Ghrelin and cardiovascular diseases.

Authors:  Gaigai Zhang; Xinhua Yin; Yongfen Qi; Lakshmana Pendyala; Jack Chen; Dongming Hou; Chaoshu Tang
Journal:  Curr Cardiol Rev       Date:  2010-02

3.  The comparison of the impact of ghrelin and tacrolimus on vitreous cytokine levels in an experimental uveitis model.

Authors:  Fatih Cem Gül; Burak Turgut; Ferda Dağlı; Nevin Ilhan; Metin Özgen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-19       Impact factor: 3.117

4.  Relaxant effect of ghrelin on guinea pig isolated tracheal smooth muscle: role of epithelial NO and PGE2.

Authors:  Mohammed Saeed Zayed Al-Ayed
Journal:  Pflugers Arch       Date:  2018-02-26       Impact factor: 3.657

5.  Comparison of total/active ghrelin levels in primary open angle glaucoma, pseudoexfoliation glaucoma and pseudoexfoliation syndrome.

Authors:  Numan Eraslan; Ufuk Elgin; Emine Şen; Aytul Kilic; Pelin Yilmazbas
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

6.  Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model.

Authors:  Nagehan Can; Onur Catak; Burak Turgut; Tamer Demir; Nevin Ilhan; Tuncay Kuloglu; Ibrahim Hanifi Ozercan
Journal:  Drug Des Devel Ther       Date:  2015-06-02       Impact factor: 4.162

7.  Potentiality of ghrelin as antioxidant and protective agent.

Authors:  Rachid Akki; Kawtar Raghay; Mohammed Errami
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

8.  Impact of ghrelin on vitreous cytokine levels in an experimental uveitis model.

Authors:  Burak Turgut; Fatih Cem Gül; Ferda Dağli; Nevin Ilhan; Metin Özgen
Journal:  Drug Des Devel Ther       Date:  2013-01-09       Impact factor: 4.162

Review 9.  New therapeutic targets for intraocular pressure lowering.

Authors:  A Rocha-Sousa; J Rodrigues-Araújo; Petra Gouveia; João Barbosa-Breda; S Azevedo-Pinto; P Pereira-Silva; A Leite-Moreira
Journal:  ISRN Ophthalmol       Date:  2013-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.